BIOMAT Database Logo BIOMAT Database Logo

Molecular interactions in T-cell-mediated cytotoxicity. 1983

B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010504 Periodic Acid A strong oxidizing agent. Paraperiodic Acid,Periodic Acid (HIO4),Periodic Acids,Acid, Paraperiodic,Acid, Periodic,Acids, Periodic
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic

Related Publications

B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
T-cell-mediated cytotoxicity.
June 1991, Current opinion in immunology,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
Molecular interactions in T-cell mediated cytotoxicity: discrimination between the binding and lethal hit stages of cytolysis.
January 1982, Advances in experimental medicine and biology,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
17th forum in immunology: Molecular mechanisms of T-cell-mediated cytotoxicity.
January 1987, Annales de l'Institut Pasteur. Immunology,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
On T-cell-mediated cytotoxicity.
December 1973, Transplantation proceedings,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
T-cell mediated autoimmunity: molecular interactions and therapeutic implications.
August 1990, Journal of autoimmunity,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
Molecular mechanisms in cell-mediated cytotoxicity.
July 1997, Cell,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
Fas-based T cell-mediated cytotoxicity.
January 1995, Current topics in microbiology and immunology,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
A molecular biology approach to the mechanism of T-cell-mediated cytotoxicity.
January 1987, Annales de l'Institut Pasteur. Immunology,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
Molecular interactions in human T-cell-mediated cytotoxicity to Epstein-Barr virus. I. Blocking of effector cell function by monoclonal antibody OKT3.
May 1982, Cellular immunology,
B Bonavida, and T Bradley, and J Fan, and J Hiserodt, and R Effros, and H Wexler
Natural cell-mediated cytotoxicity in cutaneous T-cell lymphomas.
August 1983, The Journal of investigative dermatology,
Copied contents to your clipboard!